Proteomic Assessment of iTRAQ-Based NaoMaiTong in the Treatment of Ischemic Stroke in Rats

<table class="fixed-width table-group" id="tab2"><tr><td><table class="table"><colgroup><col style="width:7.96em"/><col style="width:10.19em"/><col style="width:10.19em"/></colgroup><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Corresponding experimental batch </td><td class="align_center">Number of trusted proteins identified (excluding duplicate proteins)</td><td class="align_center">Number of trusted proteins identified (repeated proteins are not excluded)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Run 1</td><td class="align_center">4636</td><td class="align_center">4667</td></tr><tr><td class="align_left">Run 2</td><td class="align_center">4679</td><td class="align_center">4716</td></tr><tr><td class="align_left">Run 3</td><td class="align_center">4482</td><td class="align_center">4521</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Statistical results of trusted proteins.</div>

Evidence-Based Complementary and Alternative Medicine

tab2

Table 2

Table 2: Proteomic Assessment of iTRAQ-Based NaoMaiTong in the Treatment of Ischemic Stroke in Rats 